| Johanne Champigny, OTR | |
|
81 Medical Village Dr, Suite 3, Newport, VT 05855-9835 | |
| (180) 233-4326 | |
| (180) 233-4416 |
| Full Name | Johanne Champigny |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 81 Medical Village Dr, Newport, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851501100 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 072-0000158 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Johanne Champigny, OTR 580 Route De Mansonville, Mansonville, QUEBEC J0E 1-X0 Ph: (145) 029-20577 | Johanne Champigny, OTR 81 Medical Village Dr, Suite 3, Newport, VT 05855-9835 Ph: (180) 233-4326 |
News Archive
Delinquent youth are more likely to have high-risk HIV/AIDS sexual behaviors as they age, including multiple sexual partners and unprotected vaginal sex with a high-risk partner, reports a Northwestern Medicine study. The study tracked the youth 14 years after detention.
Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.
A group of 40 students are part of Saint Louis University's Student National Medical Association chapter (SNMA), who are striving to reduce health disparities locally. This year, they received the Leadership in Institutional Diversity Award, a recognition given to a university for serving as an outstanding example of leadership and innovation in promoting and maintaining institutional diversity.
Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has received a grant of $244,479 from the United States Government to help fund the Company's Phase I clinical trial of its lead cancer drug candidate Liposomal Grb-2. The amount of funds awarded was the maximum allocation allowed under the program.
› Verified 4 days ago
Desiree Ann Rice, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 35 Bel Aire Dr, Newport, VT 05855 Phone: 802-334-2878 | |
Kristen L Wozniak, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 81 Medical Village Dr Ste 3, Newport, VT 05855 Phone: 802-334-3260 | |
Gail Waecker, M.S. OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 35 Bel Aire Dr, Newport, VT 05855 Phone: 802-334-2878 | |
Larissa Hine, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 189 Prouty Dr, Newport, VT 05855 Phone: 802-334-7331 |